Maanshan Iron & Steel Co Ltd (600808)
Shanghai Stock Exchange · China · prices in CNY · close of 21 Oct 2026
Key indicators
| Last close | CNY 2.350 |
|---|---|
| 52-week range | 2.330 – 4.540 |
| Return, 1 month / 3 months | −8.9% / −5.6% |
| Return, 1 year / 3 years | −41.1% / −9.6% |
| Trend | Below its 200-day average |
| RSI (14) | 38 |
| Volatility (1 year) | 35.8% |
| Worst drawdown (1 year) | -47.3% |
| Average daily value traded | 159.45M CNY |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Maanshan Iron & Steel is a Chinese steelmaker based in Ma'anshan, Anhui province. It makes steel products such as sections, wire rod, plates, and hot-rolled and cold-rolled coils, along with related by-products. Its customers are mainly industrial users, construction firms and manufacturers that need steel for buildings, machinery and transport equipment. The company operates as part of the Magang group and serves markets in China and abroad through its steelmaking and processing operations.
Maanshan Iron & Steel Co Ltd trades under the code 600808 on the Shanghai Stock Exchange in China, with its price quoted in Chinese yuan (CNY). Our dividend records, which start in 2019, show payments in 5 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Maanshan Iron & Steel Co Ltd (600808) trades on the Shanghai Stock Exchange in China. It last closed at CNY 2.350 on 21 October 2026.
Its price-based Market X-Ray is 34 out of 100 (a weak price profile), ranking 1,819 of 2,278 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 41.1% and over the last three months it fell 5.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Shanghai Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 15 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -28.2% | ||
| From 52-week high | -47.1% | ||
| Momentum | 20 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -5.6% | ||
| 6-month return | -40.7% | ||
| 12-month return, skipping the last month | -35.3% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 35.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -47.3% | ||
| Liquidity | 55 · Fair | Moderate trading activity. | |
| Average daily value traded | 159.45M CNY | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −2.1% |
|---|---|
| 1 month | −8.9% |
| 3 months | −5.6% |
| 6 months | −40.7% |
| 1 year | −41.1% |
| 3 years | −9.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 2.521 / 3.273 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 0.075 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Jul 2023 | CNY 0.0200 |
| 21 Jul 2022 | CNY 0.3500 |
| 29 Jul 2021 | CNY 0.1300 |
| 29 Jul 2020 | CNY 0.0800 |
| 12 Jul 2019 | CNY 0.3100 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Shanghai Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.